Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies.
Experimental vaccines, which independently achieve 48% and 68% reductions in malaria cases, can achieve 91% reduction when combined.
Presently, each vaccine is at a different stage of human trials, and there have not been efforts to combine them. However, a team led by Imperial College London have now tested the effectiveness when using the two types of vaccine together.
Reaching a potential 91% reduction in cases would have a huge impact on public health because the vaccines could be effective in areas where malaria is more prevalent.Dr Andrew Blagborough
The study, published today in the journal eLife, used genetically altered mouse parasites that express proteins expressed on the human version of the malaria parasite. The research was funded by the PATH’s Malaria Vaccine Initiative and the Medical Research Council (MRC), including researchers at Imperial’s MRC Centre for Outbreak Analysis and Modelling.
Lead researcher Dr Andrew Blagborough, from the Department of Life Sciences at Imperial, said: “This is the first direct evidence than combining vaccines of different types significantly improves their efficacy in terms of reducing malarial burden.
“Reaching a potential 91% reduction in cases would have a huge impact on public health because the vaccines could be effective in areas where malaria is more prevalent.”
Two types of vaccines
Malaria is caused by a group of parasites that have a complex life cycle, spending time in the mosquito midgut and salivary glands, in the human liver, and circulating in human blood, where they cause the disease.
The team tested two types of vaccines: those that prevent mosquitoes from transferring the parasites, called transmission-blocking vaccines (TBVs), and those that prevent the parasite from infecting the liver, termed pre-erythrocytic vaccines (PEVs).
RTS,S is the world’s first PEV malaria vaccine that has been shown to provide partial protection against malaria in young children by blocking infection of the liver. However, its maximum efficacy is under 50% (i.e. it reduces cases by around 50%).
There are currently several types of transmission-blocking vaccines in early trials, which are thought to reduce the number of parasites in the mosquito salivary glands. Their efficacy typically ranges from around 50-95%.
It has been assumed that combining these vaccines would increase their efficacy, but it has never been tested until now. The team found that when a partially effective PEV was combined with the most effective transmission-blocking vaccine, the efficacy was around 91%.
The team also found that combining any of the two types of vaccines improved efficacy of the mixture more than might be expected from the single efficacy of each vaccine separately.
Working towards elimination
Dr Morven Roberts, Programme Manager for parasites and neglected tropical diseases at the MRC, said: “While these findings are in the preliminary stages, they’re valuable as they shed light on optimising strategies for preventing malaria. Learning that combining vaccines can dramatically boost efficacy in mice provides another potential tactic for controlling this disease. This is timely research as global health officials work towards WHO targets to eliminate malaria by 2030.”
The team will next study how combined vaccines could work in more complex situations. Dr Blagborough said: “In the real world, the vaccine coverage we can achieve– how many people we can give it to – is important, as are the local levels of transmission, and how prevalent malaria currently is in that area.
“We plan to use a combination of rodent experiments and computer modelling to help us estimate effectiveness requirements for future vaccines.”
The efficacy of current lead malaria vaccines is known to reduce over time after vaccines are administered, so the team will also investigate how combined vaccines perform in the long term.
The Latest on: Malaria
via Google News
The Latest on: Malaria
Gold Fields school complex wins malaria quiz competition
on June 15, 2019 at 7:02 pm
Gold Fields school complex in the Tarkwa-Nsuaem Municipality has won the 2019 inter-schools world malaria day quiz competition organised by Gold Fields Ghana Limited (GFGL), Tarkwa mines. The ... […]
Scripps Research forges ahead with drugs for arthritis, malaria and cancer
on June 14, 2019 at 2:56 pm
Early next year, the world will learn whether an inevitable part of aging — osteoarthrits — may not be inevitable after all. That’s when preliminary results are expected about an osteoarthritis drug ... […]
Malaria Vaccines Market to Experience a Huge Trajectory Growth Till 2024
on June 14, 2019 at 9:02 am
Jun 14, 2019 (News AIM via COMTEX) -- Nearly half of the global population is at risk of malaria as per stats released by the World Health Organization (WHO). This in turn has led to increased ... […]
Mermithid nematodes to control malaria transmission
on June 14, 2019 at 1:10 am
In malaria endemic Africa, chemicals are intensively used to control mosquitoes. Malaria is a vector-borne disease transmitted by female Anopheles mosquitoes. These mosquitoes reproduce in collections ... […]
Identification of protective antibodies may be key to effective malaria vaccine
on June 13, 2019 at 8:04 am
Researchers from the University of Oxford, along with partners from five institutions around the world, have identified the human antibodies that prevent the malaria parasite from entering blood ... […]
Malaria Diagnostics: Researcher 3D Prints Microscope Accessory for Imaging on Smartphones
on June 12, 2019 at 9:35 pm
In ‘3D-Printed Microscope Accessory: Affordable Technology for Efficient Diagnostics,’ Nicholas Addy-Tayie explores the use of progressive techniques to create better microscopy in malaria ... […]
Human protein that aids development of malaria parasite identified
on June 12, 2019 at 3:40 pm
Researchers have discovered that the Plasmodium parasites responsible for malaria rely on a human liver cell protein for their development into a form capable of infecting red blood cells and causing ... […]
Researchers identify human protein that aids development of malaria parasite
on June 12, 2019 at 6:07 am
Researchers in Japan have discovered that the Plasmodium parasites responsible for malaria rely on a human liver cell protein for their development into a form capable of infecting red blood cells ... […]
Latest Buzz: Malaria Drug May Help Prevent Genetic Hearing Loss
on June 12, 2019 at 5:00 am
Besides the cringe-worthy sounds that mosquitoes make while fluttering around your ears, in search of their next meal, we don’t typically think of malaria and hearing loss in the same scientific ... […]
via Bing News